198 related articles for article (PubMed ID: 12678764)
1. Targeting p53 in cancer.
Chène P
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):151-61. PubMed ID: 12678764
[TBL] [Abstract][Full Text] [Related]
2. New p53-based anti-cancer therapeutic strategies.
Wiman KG
Med Oncol; 1998 Dec; 15(4):222-8. PubMed ID: 9951684
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic exploitation of the p53 pathway.
Lane DP; Lain S
Trends Mol Med; 2002; 8(4 Suppl):S38-42. PubMed ID: 11927286
[TBL] [Abstract][Full Text] [Related]
4. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
5. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
[TBL] [Abstract][Full Text] [Related]
7. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy in human cancer: report of human clinical trials.
Wasil T; Buchbinder A
Cancer Invest; 2000; 18(8):740-6. PubMed ID: 11107444
[No Abstract] [Full Text] [Related]
9. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus p53 gene therapy.
Roth JA
Expert Opin Biol Ther; 2006 Jan; 6(1):55-61. PubMed ID: 16370914
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in p53 research and cancer treatment.
Suzuki K; Matsubara H
J Biomed Biotechnol; 2011; 2011():978312. PubMed ID: 21765642
[TBL] [Abstract][Full Text] [Related]
12. Improving cancer therapy by non-genotoxic activation of p53.
Lain S; Lane D
Eur J Cancer; 2003 May; 39(8):1053-60. PubMed ID: 12736103
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of the p53 tumor suppressor gene.
Beaudry GA; Bertelsen AH; Sherman MI
Curr Opin Biotechnol; 1996 Dec; 7(6):592-600. PubMed ID: 8939636
[TBL] [Abstract][Full Text] [Related]
14. Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.
Li Y; Li B; Li CJ; Li LJ
Expert Opin Biol Ther; 2015 Mar; 15(3):437-54. PubMed ID: 25496374
[TBL] [Abstract][Full Text] [Related]
15. Use of suicide genes for cancer gene therapy: study of the different approaches.
Vassaux G; Martin-Duque P
Expert Opin Biol Ther; 2004 Apr; 4(4):519-30. PubMed ID: 15102601
[TBL] [Abstract][Full Text] [Related]
16. Methods for screening tumors for p53 status and therapeutic exploitation.
Tullo A; D'Erchia AM; Sbisà E
Expert Rev Mol Diagn; 2003 May; 3(3):289-301. PubMed ID: 12779005
[TBL] [Abstract][Full Text] [Related]
17. INGN 201 (Advexin): adenoviral p53 gene therapy for cancer.
Gabrilovich DI
Expert Opin Biol Ther; 2006 Aug; 6(8):823-32. PubMed ID: 16856803
[TBL] [Abstract][Full Text] [Related]
18. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
Heise C; Lemmon M; Kirn D
Clin Cancer Res; 2000 Dec; 6(12):4908-14. PubMed ID: 11156251
[TBL] [Abstract][Full Text] [Related]
19. The role of mutant p53 in human cancer.
Goh AM; Coffill CR; Lane DP
J Pathol; 2011 Jan; 223(2):116-26. PubMed ID: 21125670
[TBL] [Abstract][Full Text] [Related]
20. P53 gene replacement for cancer--interactions with DNA damaging agents.
Roth JA; Grammer SF; Swisher SG; Komaki R; Nemunaitis J; Merritt J; Meyn RE
Acta Oncol; 2001; 40(6):739-44. PubMed ID: 11765069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]